Financial News
Latest News about VRTX
Recent news which mentions VRTX
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2022
January 20, 2022
From Benzinga
10 Biggest Price Target Changes For Thursday
January 20, 2022
From Benzinga
4 Unstoppable Stocks That Can Run Circles Around Shiba Inu in 2022
January 19, 2022
From Motley Fool
Buy These Stocks If You Want 126% to 206% Returns, Says Wall Street
January 18, 2022
From Motley Fool
Is Beam Therapeutics a Good Stock to Buy Now?
January 16, 2022
From Motley Fool
3 Cathie Wood Stocks That Could Deliver Bigger Gains Than the Market
January 16, 2022
From Motley Fool
From Benzinga
4 Biotech Acquisitions We'd Like to See in 2022
January 14, 2022
From Motley Fool
The Top Stocks These Investors Plan on Buying Soon
January 10, 2022
From Motley Fool
3 No-Brainer Big Pharma Stocks to Buy in 2022
January 09, 2022
From Motley Fool
Better Buy: Vertex Pharmaceuticals vs. Biogen
January 07, 2022
From Motley Fool
A Bullish Sign Appears On Vertex Pharmaceuticals's Chart
January 06, 2022
Tickers
VRTX
From Benzinga
Cramer Gives His Opinion On Oppenheimer Holdings, Mosaic And More
January 05, 2022
From Benzinga
7 Stocks That Could Make You Richer in 2022
January 05, 2022
From Motley Fool
Better Buy: CRISPR vs. Intellia
January 03, 2022
From Motley Fool
Where to Invest $100,000 in 2022
January 02, 2022
From Motley Fool
2 Best Stocks to Invest $5,000 in Right Now
January 01, 2022
From Motley Fool
Vertex Pharmaceuticals Stock: Bull vs. Bear
December 31, 2021
From Motley Fool
2 Unstoppable Stocks That Could Go Parabolic
December 30, 2021
From Motley Fool
$100 Invested In This Stock 10 Years Ago, Would Be Worth This Much
December 29, 2021
Tickers
VRTX
From Benzinga
3 Biotech Stocks That Sank in 2021 but Could Soar in 2022
December 26, 2021
From Motley Fool
3 Healthcare Stocks to Buy If You're Worried About a Market Crash
December 21, 2021
From Motley Fool
3 Biotech Stocks That Are Too Cheap to Ignore
December 19, 2021
From Motley Fool
5 Unstoppable Trends to Invest $5,000 In for 2022
December 19, 2021
From Motley Fool
3 Biotech Stocks That Could Make You Richer in December (and Beyond)
December 12, 2021
From Motley Fool
Could Vertex Have a Cure for Type 1 Diabetes on the Way?
December 11, 2021
Tickers
VRTX
From Motley Fool
Got $1,000? These 3 Stocks Could Be Bargain Buys for 2022 and Beyond
December 10, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
From Benzinga
3 Beaten-Down Biotech Stocks -- Are They Bargains Now?
December 08, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.